Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1983 Dec;24(6):876–882. doi: 10.1128/aac.24.6.876

Orally administered ketoconazole: route of delivery to the human stratum corneum.

R Harris, H E Jones, W M Artis
PMCID: PMC185400  PMID: 6318663

Abstract

Delivery of ketoconazole to human stratum corneum was studied. Thirteen healthy volunteers, three patients with chronic fungal disease and one patient with palmar-plantar hyperhidrosis were given 400 mg of ketoconazole daily for various lengths of time. The ketoconazole content of palmar stratum corneum, eccrine sweat, sebum, and serum was measured by high-pressure liquid chromatography (sensitivity, 0.005 to 0.010 microgram/ml). Palmar stratum corneum obtained after 7 and 14 days of daily administration contained up to 14 micrograms of ketoconazole per g. Ketoconazole was not found in sebum after 7 or 14 days of daily ingestion of the antimycotic agent. Sebum from three patients with chronic fungal infection treated for greater than 9 months contained ketoconazole (means, 4.7 micrograms/g). Thermogenic whole body eccrine sweat contained a mean of 0.059 microgram/ml on day 7 and 0.084 microgram/ml on day 14 of daily administration. Ketoconazole appeared in thermogenic whole body eccrine sweat and palmar hyperhidrotic sweat within 1 h after a single oral dose. Partition studies of ketoconazole containing eccrine sweat demonstrated a 10-fold greater concentration in the sediment phase (desquamated keratinocytes) compared with the clear supernatant phase. In vitro studies with [3H]ketoconazole-supplemented supernatant sweat revealed preferential binding to stratum corneum, hair, and nails and its partitioning to lipid-rich sebum. We conclude that eccrine sweat rapidly transports ketoconazole across the blood-skin barrier, where it may bind or partition to keratinocytes and surface lipids.

Full text

PDF
876

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alton K. B. Determination of the antifungal agent, ketoconazole, in human plasma by high-performance liquid chromatography. J Chromatogr. 1980 Dec 12;221(2):337–344. doi: 10.1016/s0378-4347(00)84319-4. [DOI] [PubMed] [Google Scholar]
  2. Elias P. M., Brown B. E. The mammalian cutaneous permeability barrier: defective barrier function is essential fatty acid deficiency correlates with abnormal intercellular lipid deposition. Lab Invest. 1978 Dec;39(6):574–583. [PubMed] [Google Scholar]
  3. Epstein W. L., Shah V. P., Riegelman S. Griseofulvin levels in stratum corneum. Study after oral administration in man. Arch Dermatol. 1972 Sep;106(3):344–348. [PubMed] [Google Scholar]
  4. Jones H. E., Simpson J. G., Artis W. M. Oral ketoconazole. An effective and safe treatment for dermatophytosis. Arch Dermatol. 1981 Mar;117(3):129–134. doi: 10.1001/archderm.117.3.129. [DOI] [PubMed] [Google Scholar]
  5. Maksymiuk A. W., Levine H. B., Bodey G. P. Pharmacokinetics of ketoconazole in patients with neoplastic diseases. Antimicrob Agents Chemother. 1982 Jul;22(1):43–46. doi: 10.1128/aac.22.1.43. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Petersen E. A., Alling D. W., Kirkpatrick C. H. Treatment of chronic mucocutaneous candidiasis with ketoconazole: a controlled clinical trial. Ann Intern Med. 1980 Dec;93(6):791–795. doi: 10.7326/0003-4819-93-6-791. [DOI] [PubMed] [Google Scholar]
  7. Ramasastry P., Downing D. T., Pochi P. E., Strauss J. S. Chemical composition of human skin surface lipids from birth to puberty. J Invest Dermatol. 1970 Feb;54(2):139–144. doi: 10.1111/1523-1747.ep12257164. [DOI] [PubMed] [Google Scholar]
  8. Robertson M. H., Rich P., Parker F., Hanifin J. M. Ketoconazole in griseofulvin-resistant dermatophytosis. J Am Acad Dermatol. 1982 Feb;6(2):224–229. doi: 10.1016/s0190-9622(82)70015-5. [DOI] [PubMed] [Google Scholar]
  9. Scheuplein R. J., Blank I. H. Permeability of the skin. Physiol Rev. 1971 Oct;51(4):702–747. doi: 10.1152/physrev.1971.51.4.702. [DOI] [PubMed] [Google Scholar]
  10. Shah V. P., Epstein W. L., Riegelman S. Role of sweat in accumulation of orally administered griseofulvin in skin. J Clin Invest. 1974 Jun;53(6):1673–1678. doi: 10.1172/JCI107718. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Urcuyo F. G., Zaias N. The successful treatment of pityriasis versicolor by systemic ketoconazole. J Am Acad Dermatol. 1982 Jan;6(1):24–25. doi: 10.1016/s0190-9622(82)80198-9. [DOI] [PubMed] [Google Scholar]
  12. Weinstein G. D. Cell kinetics of human sebaceous glands. J Invest Dermatol. 1974 Mar;62(3):144–146. doi: 10.1111/1523-1747.ep12676778. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES